Five things for pharma marketers to know: Thursday, June 13, 2019
Catalyst sues FDA; Facebook alerts blood donors; How do you deal with trolls?
Most recent articles by Carrie Gavit
Five things for pharma marketers to know: Thursday, June 6, 2019
Ohio doctor faces 25 murder counts for prescribing excess opioid doses; MyCME wins award; Sharpless disputes drug pricing coverage.
Five things for pharma marketers to know: Thursday, May 30, 2019
The FDA agrees to priority review of Amarin’s Vascepa; Oklahoma opioid trial continues; W2O receives new private equity investment.
Five things for pharma marketers to know: Thursday, May 23, 2019
The FDA under Sharpless; Lilly sells half-price version of insulin; Maine confirms measles case.
Meet the 2019 Cannes Lions Health juries
The Cannes Lions International Festival of Creativity is set for June 17-21 in the South of France.
Five things for pharma marketers to know: Friday, May 17, 2019
Five more states sue Purdue; Met to no longer take donations from Sacklers; Nestle plans sale of skincare line.
Five things for pharma marketers to know: Thursday, May 16, 2019
North Carolina sues Juul; J&J plans 10 drug launches by 2023; Novartis could settle kickback suit.
Five things for pharma marketers to know: Thursday, May 9, 2019
MM&M’s Transforming Healthcare conference; Trump administration moves forward with drug-price-in-advertising requirement; Walmart raises minimum age to buy tobacco.
Five things for pharma marketers to know: Thursday, May 2, 2019
Humana CEO won’t back “Medicare for all”; FDA rejects Heron non-opioid painkiller; GSK predicts shingles vaccine will top $1.3b in sales this year.
Five things for pharma marketers to know: Thursday, April 25, 2019
Melinda Gates urges vaccinations; Trump speech on opioid crisis; Pfizer annual shareholder meeting.
